摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2,3,4-Tetrahydro-6-methoxy-2-[[(4-methoxy phenyl)amino]carbonyl]-5 (phenylmethoxy)-3-isoquinolinecarboxylic acid | 152362-56-6

中文名称
——
中文别名
——
英文名称
1,2,3,4-Tetrahydro-6-methoxy-2-[[(4-methoxy phenyl)amino]carbonyl]-5 (phenylmethoxy)-3-isoquinolinecarboxylic acid
英文别名
5-Benzyloxy-6-methoxy-2-(4-methoxy-phenylcarbamoyl)-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid;6-methoxy-2-[(4-methoxyphenyl)carbamoyl]-5-phenylmethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid
1,2,3,4-Tetrahydro-6-methoxy-2-[[(4-methoxy phenyl)amino]carbonyl]-5 (phenylmethoxy)-3-isoquinolinecarboxylic acid化学式
CAS
152362-56-6
化学式
C26H26N2O6
mdl
——
分子量
462.502
InChiKey
PSJJMQJLCQVKBX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    34
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    97.3
  • 氢给体数:
    2
  • 氢受体数:
    6

文献信息

  • SUBSTITUTED 1,2,3,4-TETRAHYDROISOQUINOLINES WITH ANGIOTENSIN II RECEPTOR ANTAGONIST PROPERTIES
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP0641326A1
    公开(公告)日:1995-03-08
  • Method of Treatment or Prophylaxis of Inflammatory Pain
    申请人:Spinifex Pharmaceuticals Pty Ltd
    公开号:US20140142116A1
    公开(公告)日:2014-05-22
    A method of treatment, reversal and/or symptomatic relief of inflammatory pain, including hyperalgesia, thermal or mechanical allodynia, in vertebrate animals, particularly in human subjects, comprising administering angiotensin II receptor 2 (AT 2 receptor) antagonists is disclosed. The AT 2 receptor antagonist may be provided alone or in combination with other compounds such as those that are useful in the control of inflammatory pain.
  • METHOD OF TREATMENT OR PROPHYLAXIS INFTAMMATORY PAIN
    申请人:Novartis AG
    公开号:US20160052925A1
    公开(公告)日:2016-02-25
    A method of treatment, reversal and/or symptomatic relief of inflammatory pain, including hyperalgesia, thermal or mechanical allodynia, in vertebrate animals, particularly in human subjects, comprising administering angiotensin II receptor 2 (AT 2 receptor) antagonists is disclosed. The AT 2 receptor antagonist may be provided alone or in combination with other compounds such as those that are useful in the control of inflammatory pain.
  • US5246943A
    申请人:——
    公开号:US5246943A
    公开(公告)日:1993-09-21
  • US5350757A
    申请人:——
    公开号:US5350757A
    公开(公告)日:1994-09-27
查看更多